Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Grant awarded to cornea specialist Dr. James Chodosh

Research to Prevent Blindness (RPB) has granted Massachusetts Eye and Ear Infirmary cornea specialist James Chodosh, M.D., M.P.H., a $150,000 Senior Scientific Investigator Award. RPB Senior Scientific Investigator Awards support nationally recognized scientists conducting eye research at medical institutions in the United States.

Dr. Chodosh is internationally respected for his work on viral infections of the eye, and has worked for more than 20 years to elucidate the causes of visual loss in epidemic keratoconjunctivitis (EKC), an Adenoviral infection commonly known as pink eye. The purpose of Dr. Chodosh's RPB-funded study is to identify those characteristics of the virus that cause inflammation in the Adenovirus-infected cornea. If successful, his work should allow prediction of which new Adenoviruses are likely to become causes of EKC, and aid in understanding how corneal inflammation (and poor vision) is caused.

"We are very grateful to Research to Prevent Blindness for their support. Their funding is vital to our on-going research, such as that being done by Dr. Chodosh, to determine the factors involved in vision loss. This is work that will lead to providing the best treatment for our patients and ultimately, patients everywhere," said Dr. Joan W. Miller, Chief of Ophthalmology at Mass. Eye and Ear and Mass General Hospital, and Chair of Ophthalmology at Harvard Medical School.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long-term low-dose antiviral treatment reduces eye disease risk from shingles